{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:22:22Z","timestamp":1777576942747,"version":"3.51.4"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.juro.2013.11.005","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T06:45:46Z","timestamp":1384152346000},"page":"1244-1249","source":"Crossref","is-referenced-by-count":49,"title":["5-Year Outcome of a Randomized Prospective Study Comparing bacillus Calmette-Gu\u00e9rin with Epirubicin and Interferon-\u03b12b in Patients with T1 Bladder Cancer"],"prefix":"10.1097","volume":"191","author":[{"given":"Tammer","family":"Hemdan","sequence":"first","affiliation":[{"name":"Departments of Urology and Surgical Sciences, University Hospital Uppsala, Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Johansson","sequence":"additional","affiliation":[{"name":"Oncological Center, Ume\u00e5 University Hospital, Ume\u00e5, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staffan","family":"Jahnson","sequence":"additional","affiliation":[{"name":"Department of Urology, University Hospital Link\u00f6ping, Link\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pekka","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Urology, University Central Hospital, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilker","family":"Tasdemir","sequence":"additional","affiliation":[{"name":"Department of Urology, Central Hospital of Rogaland, Stavanger, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per-Uno","family":"Malmstr\u00f6m","sequence":"additional","affiliation":[{"name":"Departments of Urology and Surgical Sciences, University Hospital Uppsala, Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Members of the Urothelial Cancer Group of the Nordic Association of Urology","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.11.005_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.eururo.2009.09.038","article-title":"Bacillus Calmette-Gu\u00e9rin is superior to a combination of epirubicin and interferon-alpha2b in\u00a0the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective, randomized, Nordic study","volume":"57","author":"Duchek","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1464-410X.1995.tb00759.x","article-title":"A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Finnish Multicentre Study Group","volume":"76","author":"Raitanen","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0302-2838(03)00140-4","article-title":"Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a Nordic study","volume":"43","author":"Kaasinen","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2012.09.063","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: pathology","volume":"63","author":"Amin","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S1078-1439(03)00144-3","article-title":"Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy","volume":"22","author":"Bianco","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2013.11.005_bib7","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1464-410X.2004.05228.x","article-title":"The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour","volume":"94","author":"Solsona","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2013.11.005_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/B:UROL.0000032688.37789.7c","article-title":"T1G3 bladder cancer\u2013indications for early cystectomy","volume":"36","author":"Masood","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.juro.2013.11.005_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","article-title":"Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a\/b\/c) in BCG-treated and BCG-non-treated patients","volume":"48","author":"Orsola","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in\u00a0individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: multivariate analysis of\u00a0data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.juro.2006.08.070","article-title":"Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?","volume":"177","author":"Herr","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(01)61607-0","article-title":"5-Year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study Group","volume":"161","author":"Malmstr\u00f6m","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.11.005_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.eururo.2007.06.030","article-title":"Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?","volume":"53","author":"Denzinger","year":"2008","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713058990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713058990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.11.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:28:53Z","timestamp":1651202933000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.11.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1016\/j.juro.2013.11.005"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.11.005","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}